Spain (ES)

Force spectroscopy predicts thermal stability of immobilized proteins by measuring microbead mechanics (2016) Gregurec D, Velasco-Lozano S, Moya SE, Vazquez L, Lopez-Gallego F Journal article ECM-Regulator timp Is Required for Stem Cell Niche Organization and Cyst Production in the Drosophila Ovary (2016) Pearson JR, Zurita F, Tomas-Gallardo L, Diaz-Torres A, Del Carmen Diaz De La Loza M, Franze K, Martin-Bermudo MD, Gonzalez-Reyes A Journal article On the magnetic properties of iron nanostructures fabricated via focused electron beam induced deposition and autocatalytic growth processes (2016) TU F, Drost M, Vollnhals F, Späth A, Carrasco E, Fink R, Marbach H Journal article Optimizing CuO p-type dye-sensitized solar cells by using a comprehensive electrochemical impedance spectroscopic study (2016) Langmar O, Ganivet CR, De La Torre G, Torres T, Costa RD, Guldi DM Journal article Steering the formation of supported Pt-Sn nanoalloys by reactive metal-oxide interaction (2016) Neitzel A, Kovacs G, Lykhach Y, Tsud N, Kozlov SM, Skala T, Vorokhta M, et al. Journal article Conodonts from the Lower Ordovician of Morocco – a contribution to the faunal diversity in the famous Fezouata Lagerstätte (2016) Lehnert O, Nowak H, Sarmiento G, Servais T, Gutiérrez-Marco JC, Akodad M Journal article Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials (2016) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Conference contribution Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2016) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials (2016) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS (2016) Gladman DD, Kavanaugh A, Adebajo AO, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution